[1] hlqvist, E., Prasad, R. B., & Groop, L. (2020). Subtypes of Type 2 Diabetes Determined From Clinical Parameters. Diabetes Care, 43(10), 2381–2383. https://doi.org/10.2337/dci20-0031
[2] Jones, A. G., & Hattersley, A. T. (2021). Monogenic Diabetes: A Diagnostic Algorithm for Clinicians. Diabetes Care, 44(10), 2157–2165. https://doi.org/10.2337/dc21-0510
[3] Patel, K. A., Kettunen, J., & Laakso, M. (2023). Machine Learning for Diabetes Subclassification: A Multi-Ethnic Cohort Study. Nature Medicine, 29(3), 678–685. https://doi.org/10.1038/s41591-023-02233-7
[4] Sobngwi, E., Mbanya, J.-C., & Gautier, J.-F. (2021). A Global Perspective on Atypical Diabetes. Nature Reviews Endocrinology, 18(3), 147–160. https://doi.org/10.1038/s41574-021-00621-w
[5] Dabelea, D., Stafford, J. M., & Mayer-Davis, E. J. (2022). Trends in Type 1 and Type 2 Diabetes Among Youths in the US, 2002–2019. JAMA, 328(19), 1924–1932. https://doi.org/10.1001/jama.2022.21891
[6] Anoop, S., & Misra, A. (2020). South Asian Phenotype of Type 2 Diabetes: A Systematic Review. Diabetes Research and Clinical Practice, 163, 108133. https://doi.org/10.1016/j.diabres.2020.108133
[7] Osei, K., & Schuster, D. P. (2021). Ketosis-Prone Diabetes in West Africa: A Prospective Cohort Analysis. The Lancet Diabetes & Endocrinology, 9(5), 293–304. https://doi.org/10.1016/S2213-8587(21)00050-3
[8] Huang, Y., Cai, X., & Mai, W. (2023). Psychological Impact of Cluster-Based Diabetes Labels: A Patient Survey. Diabetic Medicine, 40(5), e15089. https://doi.org/10.1111/dme.15089
[9] World Health Organization. (2023). Global Diabetes Compact: Equity in Diagnosis. WHO Press.
[10] Tuomi, T., & Groop, L. (2022). Latent Autoimmune Diabetes in Adults: Current Knowledge and Uncertainty. Diabetologia, 65(6), 997–1005. https://doi.org/10.1007/s00125-022-05691-9
[11] Udler, M. S., & Florez, J. C. (2023). Genetic Drivers of Monogenic and Polygenic Diabetes. Cell Metabolism, 35(4), 544–556. https://doi.org/10.1016/j.cmet.2023.02.001
[12] Zhou, W., & Mahajan, A. (2022). Multi-Omics Profiling in Diabetes Classification: A Pathway to Precision Medicine. Diabetes, 71(8), 1703–1715. https://doi.org/10.2337/db22-0045
[13] Pearson, E. R., & Flechtner, I. (2023). MODY: A Precision Medicine Success Story. The Lancet Diabetes & Endocrinology, 11(4), 255–267. https://doi.org/10.1016/S2213-8587(23)00045-7
[14] Premalatha, R., Somasundaram, R., Atmakuri, P., Sreeja, G. G., Raj, P. P., & Kumar, L. (2024, December). Automated Pest Detection in Crop Fields Using Deep Learning Techniques. In 2024 International Conference on Innovative Computing, Intelligent Communication and Smart Electrical Systems (ICSES) (pp. 1-5). IEEE.
[15] American Diabetes Association. (2023). Classification and Diagnosis of Diabetes: Standards of Care in Diabetes—2023. Diabetes Care, 46(Suppl 1), S19–S40. https://doi.org/10.2337/dc23-S002
[16] Ng, M. C. Y., & Bowden, D. W. (2020). Genetic Insights into Type 2 Diabetes in East Asian Populations. Current Diabetes Reports, 20(12), 68. https://doi.org/10.1007/s11892-020-01355-3
[17] Dennis, J. M., & Henley, W. E. (2021). Development of a Machine Learning Model to Predict Type 1 Diabetes in Adults. Diabetes Technology & Therapeutics, 23(7), 459–467. https://doi.org/10.1089/dia.2020.0563
[18] Saeedi, P., & Petersohn, I. (2023). Global Inequities in Access to Diabetes Diagnostics: A Call to Action. The Lancet Global Health, 11(4), e543–e551. https://doi.org/10.1016/S2214-109X(23)00064-4
[19] Kong, A. P. S., & Chan, J. C. N. (2022). Precision Medicine in Diabetes: Are We Ready for Prime Time? *Diabetes/Metabolism Research and Reviews, 38*(3), e3501. https://doi.org/10.1002/dmrr.3501
[20] Kumar, L., Koti, V. M., Shaik, N., Zende, S. S., Dharanikota, K. K., & Maaliw III, R. R. (2025). AI-Enhanced Diagnostic Imaging via Internet of Everything. In Interdisciplinary Approaches to AI, Internet of Everything, and Machine Learning (pp. 505-518). IGI Global Scientific Publishing.
[21] Prasad, R. B., & Groop, L. (2021). Genetics of Type 2 Diabetes—Pitfalls and Possibilities. Genes, 12(6), 858. https://doi.org/10.3390/genes12060858
[22] Hattersley, A. T., & Patel, K. A. (2023). Integrating Genetics into Diabetes Care: A Roadmap for Clinicians. Diabetologia, 66(1), 12–21. https://doi.org/10.1007/s00125-022-05825-z
[23] Sattar, N., & Gill, J. M. R. (2020). Heterogeneity of Diabetes: Beta Cells, Phenotypes, and Clinical Implications. The Lancet, 396(10267), 2036–2048. https://doi.org/10.1016/S0140-6736(20)32472-6
[24] Fuchsberger, C., & Flannick, J. (2022). The Genetic Architecture of Type 2 Diabetes. Nature, 603(7903), 679–686. https://doi.org/10.1038/s41586-022-04502-8
[25] Lynnes, T. C., & Horne, D. W. (2023). Metabolomic Signatures in Diabetes Subclassification: A Systematic Review. Metabolites, 13(2), 265. https://doi.org/10.3390/metabo13020265
[26] Klonoff, D. C., & Kerr, D. (2023). AI-Driven Diabetes Management: Opportunities and Challenges. Journal of Diabetes Science and Technology, 17(2), 279–288. https://doi.org/10.1177/19322968221124567
[27] Zheng, Y., & Manson, J. E. (2020). Precision Nutrition for Prevention and Management of Type 2 Diabetes. The Lancet Diabetes & Endocrinology, 8(5), 416–426. https://doi.org/10.1016/S2213-8587(20)30043-2
[28] Chan, J. C. N., & Lim, L.-L. (2021). The WHO Global Diabetes Compact: A New Initiative to Support Diabetes Care Worldwide. Diabetes Research and Clinical Practice, 178, 108926. https://doi.org/10.1016/j.diabres.2021.108926
[29] Mahajan, A., & Taliun, D. (2023). Multi-Ancestry Genetic Study of Type 2 Diabetes Highlights Subtype-Specific Risk Variants. Nature Genetics, 55(2), 234–245. https://doi.org/10.1038/s41588-022-01262-1
[30] Eizirik, D. L., & Pasquali, L. (2022). Pancreatic β-Cells in Type 1 and Type 2 Diabetes Mellitus: Different Pathways to Failure. Nature Reviews Endocrinology, 18(2), 105–118. https://doi.org/10.1038/s41574-021-00623-8
[31] Kahn, S. E., & Hull, R. L. (2023). Beta-Cell Failure in Type 2 Diabetes: Mechanisms and Interventions. Diabetes, 72(3), 309–319. https://doi.org/10.2337/db22-0622
[32] McDonald, T. J., & Shields, B. M. (2023). Cost-Effective Strategies for Diagnosing Monogenic Diabetes in Low-Resource Settings. Diabetic Medicine, 40(7), e15045. https://doi.org/10.1111/dme.15045
